Board

Executive Committee

Lee McGuire, Chair

Chief Communications Officer, Broad Institute of MIT and Harvard

Lee McGuire, Chief Communications Officer at the Broad Institute of MIT and Harvard, oversees external and internal communications, including science writing, media relations, web development, events, video, social media, and graphic design. Before joining the Broad Institute in 2015 as Director of Communications, McGuire served on the Superintendent’s executive leadership team as Chief Communications Officer for the Boston Public Schools. McGuire is a reporter by training and spent ten years as a broadcast journalist covering government and health care policy for television stations in Boise, Austin and Houston. He earned a B.A. in Politics from Princeton University and a Masters Degree in journalism from the University of Missouri-Columbia.

Uli Stilz, Chair-Elect

Board Observer, Aerska, Strategic Advisor, Jefferson Life Sciences, Senior Partner, Flagship Pioneering

Uli Stilz graduated with a Master degree in Organic Chemistry from ETH Zürich. He then moved to the Max-Planck-Institute of Biochemistry in Martinsried, where he received his Ph.D. in 1990. After postdoctoral studies at the California Institute of Technology he joined Hoechst AG were he held various positions before he was appointed Associate Vice President of the newly established Innovation unit within the Diabetes Division at Sanofi in 2010.

Over a period of 20 years, he contributed to more than 60 preclinical and clinical drug candidates across cardiometabolic, immunology, and oncology therapy areas. Between 2012 and 2014 he was President of the European Federation for Medicinal Chemistry.

In 2014, Uli joined Novo Nordisk A/S in Copenhagen and in 2019 relocated to Boston to create and lead the Novo Nordisk Bio Innovation Hub which was established in 2021.

In 2025, Uli became Board Observer at Aerska and Strategic Advisor at Jefferson Life Sciences.

Uli Stilz was appointed adjunct professor at the University of Frankfurt in 2012 and serves on Editorial Boards for international peer-reviewed journals. He is a member of several Scientific Advisory Boards in North America and Europe, and has represented Novo Nordisk A/S at trade organizations (EFPIA).

Chris Leary, Secretary

Principal | S+T Practice Lead, HOK

Chris is the practice leader for HOK’s Science + Technology group in Boston. A principal and registered architect, he leads high-performing, multidisciplinary teams delivering complex projects that support scientific discovery.

His experience spans projects for established real estate developers and large corporations as well as fast-growing commercial- and venture-backed companies. His focus on process, innovative project delivery models and building performance provides clients with highly sustainable and collaborative work and research environments.

Chris is a recognized expert on innovation district ecosystems, integrated project delivery and retrofitting historic buildings for science and tech. He frequently speaks on these topics—and more—for events hosted by organizations such as the World Economic Forum, U.S. Green Building Council, I2SL, R&D Magazine and Tradeline.

Aisha Losche, Vice-Chair

Chief Officer of Corporate and Community Engagement, Draper

Aisha Losche is the Chief Officer of Corporate and Community Engagement at Draper, where she leads initiatives aimed at enhancing corporate culture and fostering strong community relationships. With over 20 years of experience, Aisha focuses on creating collaborative partnerships and developing policies, practices, and programs that strengthen engagement both within the company and with external stakeholders. She was appointed to her current role in 2022 and works closely with Draper’s leadership team to drive impactful changes that align with corporate values and community outreach.

Aisha has a deep background in advising and coordinating engagement strategies across organizations, with a focus on cultivating sustainable partnerships and fostering a positive, inclusive work environment. Her approach to management and problem-solving has been centered around collaboration, systemic change, and the integration of efforts to enhance corporate culture and external relations.

Prior to joining Draper, Aisha served as Vice President of Talent Engagement at Publicis Groupe, where she worked for eight years leading initiatives to build talent-focused strategies that connected corporate goals with employee well-being and community involvement.

Aisha holds a B.A. in Business Administration from Sacred Heart University and an MBA from Curry College. She also completing a Corporate Citizenship Certificate at Boston College in April of 2025, and completed a Certificate in Diversity and Inclusion at Cornell University in 2018. In addition, she is a Certified Executive & Leadership Coach, Mental Health First Aider, and a Qualified Administrator for the Intercultural Development Inventory.

Denyse Medlenka, Treasurer

Chief Executive Officer, CIC

Denyse Medlenka is a versatile executive with leadership experience across multiple disciplines spanning audit and finance to human capital management and customer service in organizations of all sizes – from fast-growing startups to global enterprises – guiding teams through critical transitions. Denyse is a graduate of KPMG’s Executive Leadership Institute for Women and is a DiversityFIRST award winner from the National Diversity Council of Texas.

Margaret O’Toole, Vice Chair

Chief Executive Officer, LabCentral

Maggie O’Toole is the CEO of LabCentral, the premier Massachusetts-based network of coworking labs. Responsible for strategic operations, Maggie is a seasoned executive who brings a deep understanding of how to create spaces, community, and programming to support early-stage life sciences companies as they grow. Under Maggie’s leadership, LabCentral has grown from a single location to a six-site network of locations spanning 248,000 spare feet to support early- and later-stage biotech entrepreneurs.

In addition to community within LabCentral, Maggie is also a contributing architect and active steward of the Kendall Square community and the broader Massachusetts life sciences ecosystem.

Prior to LabCentral, Maggie served as director of operations for Pervasis Therapeutics, an early-stage biotech acquired by Shire. An accomplished speaker and member of the Executive Committee of the Board of Directors for the Kendall Square Association, Maggie holds a bachelor’s degree from Carnegie Mellon University.

Michal Preminger, Ph.D., Vice-Chair

Co-Founder and Chief Executive Officer, BioMed X Venture Labs

Michal Preminger, PhD, MBA, is a seasoned innovation leader with cross-sector experience spanning life sciences, tech, and diverse organizational settings—from startups to academia and global corporations. A recognized thought leader in biotech and healthcare, Michal is known for executing high-impact deals and influencing global innovation strategy. She serves on the boards of MassBio and the Kendall Square Association and contributes to multiple innovation-focused initiatives. She also serves as a Strategic Advisor to Jefferson Life Science Venture firm.

Her contributions were honored with the inaugural Kendall Square Founders Award.

Board of Directors

Jesse Baerkahn

President and Founder, Graffito SP

Jesse Baerkahn is the President and Founder of Graffito SP, a Boston-based commercial real estate company best described as part retail brokerage, part creative agency, and part urban design firm. Jesse’s multidisciplinary work at GSP utilizes his transactional training as an attorney and lessons learned through other entrepreneurial endeavors within the real estate, arts and entertainment fields. Jesse was previously a Director and Board Member at the Artisan’s Asylum, a non-profit makerspace in Somerville, MA, and Adjunct Faculty Member at CUNY School of Law. Jesse lives in Cambridge, MA and works out of GSP offices in Kendall Square and Boston’s Leather District.

Mark Bush

Senior Vice President of Operations for East Coast and UK Markets, BioMed Realty

Mark Bush is the Company as Senior Vice President, Operations, East Coast & UK Markets at BioMed Realty. In his position, he leads the operations and facilities functions across two core markets – Boston-Cambridge, MA, and Cambridge, UK.

Mark previously served as Senior Vice President, Asset Management at The Davis Companies, where he provided strategic oversight and direction for a portfolio of commercial real estate properties. Prior to joining The Davis Companies in 2015, Mark was Vice President, Asset Management, at AEW Capital Management, after holding positions with Brixmor Property Group and Fidelity Investments.

Mark holds a Bachelor of Science degree in Economics from Northeastern University.

Filo Castore

Vice President and Global Principal, Jacobs

Filo Castore is a Vice President and Global Principal at Jacobs, where he works with corporate real estate leaders and developers to shape workplaces, research environments, and industrial campuses. A licensed architect with more than 35 years of experience, he connects real estate strategy with design and delivery to help clients make sound investments and create places that can adapt over time.

Based in Boston, Filo has led projects across the U.S. spanning life sciences, emerging technology, and advanced manufacturing. He brings to the Kendall Square Association a commitment to sustainable development and to the connections among businesses, research institutions, and the broader community.

Tony Clark

Co-Founder & Co-President, My Brother’s Keeper Cambridge

Tony Clark is the Co-Founder and Co-President of The My Brother’s Keeper, Cambridge Taskforce. He holds degrees from Morehouse College, New York University, and The City University of New York and a Certificate in Nonprofit Leadership from Tufts University’s Jonathan M. Tisch College of Civic Life. Tony is a seasoned educator and moderator, who previously held posts at New York University, The City University of New York, Columbia University, and Johns Hopkins University. He currently serves on the English faculty of Bunker Hill Community College, as a tenured professor. His work for the United States Department of Education along with other appointments has allowed him to work closely with over 25 school districts across the United States, focusing on education reform.

Tony is an avid reader, a podcaster, and is currently working on his debut book to be released in 2022.

Michael Dawson

Co-Founder & Chief Executive Officer of Innovators for Purpose (iFp)

Michael leads Innovators for Purpose, a Cambridge-based nonprofit design and innovation studio that empowers young people, especially those from underrecognized communities, to turn curiosity into real-world impact through art + design and STEM. Under his leadership, iFp has built a continuum of youth-development programs and launched forward-looking initiatives that drive work across areas such as educational equity and equitable AI.

Michael’s 30+ year career in engineering, high-tech marketing, sales, and entrepreneurship fuels his commitment to building inclusive pathways into the innovation economy. He believes the future of innovation should be written by everyone it touches.

Michael holds a BS and MS in Electrical Engineering from the University of South Florida, and an MBA from Babson College..

Tom Evans

Executive Director and Records Access Officer, Cambridge Redevelopment Authority

Tom has led the CRA through an organizational restructuring and strategic planning process, launching new development initiatives in Kendall Square. Before coming to the CRA, Tom worked in MassDOT’s Office of Transportation Planning where he wrote sustainable transportation policies including the state’s GreenDOT Implementation Plan and the Healthy Transportation Policy Directive. Previously, Tom served as the Planning Division Manager of the San Francisco Redevelopment Agency, facilitating the planning, adoption, and implementation of signature revitalization plans along the southeast waterfront of San Francisco. He holds a Masters of City Planning from University of California and a bachelors in environmental biology.

Kelly Flynn

Head, Real Estate & Facilities, Takeda Pharmaceuticals

Kelly Flynn is the Head of Real Estate & Facilities at Takeda Pharmaceuticals, Inc., overseeing the planning and development of Takeda’s global real estate portfolio. Kelly plays a pivotal role in optimizing Takeda’s real estate assets, with over 19 years of experience managing complex real estate transactions. She is passionate about the Cambridge community and proud to have successfully negotiated the lease of Takeda’s new state-of-the-art research and development building, currently under construction at 585 Kendall, bringing the company’s U.S. R&D operations together in this cutting-edge facility.

Kelly holds a BA from St. Michael’s College in Vermont and a J.D. from Suffolk University Law School in Boston, Massachusetts.

Sarah Gallop

Director, Office of Government and Community Relations, Massachusetts Institute of Technology

Sarah serves as a liaison with the Cambridge government and community, working with citizens, public officials, businesses, regulatory bodies, and advocacy organizations on projects and issues of mutual interest. In representing MIT, she tries to bring a collaborative problem-solving approach to her interactions with Cambridge stakeholders. She thinks Kendall Square is on fire and feels privileged to be working on its behalf. Before joining MIT, Sarah worked for the City of Boston in various planning and development roles. Sarah received her BA in Political Science from Bates College and her MBA in Organizational Behavior from Boston University.

Ethan Gauvin

Head of Government Affairs, Northeast, Google

Ethan Gauvin serves as Google’s Head of Government Affairs for the Northeast, where he leads the company’s public policy engagement in the region. Ethan brings a wealth of experience in different sectors to his current role, including leadership positions on political campaigns, several years as director of public affairs for a biotech startup, and a graduate fellowship in venture capital. Ethan also previously worked at Google from 2014-2019 in San Francisco and London, where he focused on emerging technology policy issues.

Ethan holds a BA from the University of New Hampshire as well an MPA from Harvard University and a MBA from the Massachusetts Institute of Technology (MIT). In his free time, Ethan loves to travel, ski, and golf, and is always looking for a great sci-fi novel to read on his next trip.

Lisa Girard, Ph.D.

Head of Communications and Engagement, Convergent Research

Lisa Girard is the Head of Communications and Engagement at Convergent Research. Before joining Convergent Research this year, she was the Director of Strategic Communications at Whitehead Institute and founded her own consulting practice, Acropetal Strategic Communications. A former bench scientist, Girard has nearly two decades’ communications leadership and content-development experience including previous roles at California Institute of Technology, the Harvard Stem Cell Institute, and Broad Institute of MIT and Harvard as their Director of Scientific Communication. She earned her undergraduate degree from University of California, San Diego, a PhD from University of California, Berkeley, and completed postdoctoral work at California Institute of Technology.

Terry Hayes

President, Siena Construction Corporation

Terry Hayes is the President of Siena Construction, a Cambridge-based construction management firm founded in 1991. In his role, he leads a team of skilled construction and design professionals specializing in complex projects within the life-science, higher education, and commercial industries.

With nearly three decades of experience in the construction field, much of it rooted in Cambridge, Terry has overseen a wide range of projects—from multi-building campuses and historical renovations to supporting emerging companies establishing themselves locally. Over the years, he has built lasting relationships with people and organizations calling Cambridge home.

Terry resides in Arlington, MA, with his wife and two sons. He is passionate about good design, literature, theater, community service, and trying to leave things a little better than how they were found.

Keane Johnson

Managing Director & Senior HR Leader for Engineering and Research for the North American – East at Microsoft

Keane Johnson is the Managing Director & Senior HR Leader for Microsoft Engineering and Research for the North American – East. In this role, he is responsible for aligning, establishing, and driving Microsoft’s people priorities in the region.

Prior to joining Microsoft, Keane worked at Liberty Mutual for almost ten years in various HR leadership roles. He started his career working in higher education, managing student support services programs.

Keane holds a BA in Political Science, BS in Consumer Economics, and a Masters in Education, all from the University of Georgia (UGA). He also serves on the Board of Visitors for the School of Public and International Affairs at the UGA. Keane is passionate about volunteering and giving back, particularly to those organizations that enhance the availability and access to education.

Pete Joy

Vice President & General Manager, Turner Construction

Pete began his career with Turner in 2004. With 35 years of experience in the construction industry, he has played a key role in shaping the success of Turner’s operations in Boston. Over the course of his career, Pete has managed more than fifty unique projects for Turner’s Special Projects Division, earning a reputation for his collaborative leadership style, technical expertise, and commitment to excellence in client service.

In 2017, Pete was promoted to Special Projects Division Manager, where he oversaw all aspects of the Interiors and Special Projects Division (SPD) within Turner’s Boston Business Unit. Under his leadership, the SPD experienced significant growth, delivering a wide range of complex, fast-paced projects including interior renovations, fit-outs, façade restorations, MEP system upgrades, and ground-up builds. Pete’s strategic direction and emphasis on innovation and quality helped strengthen Turner’s relationships with long-standing clients and expand its market presence in the Greater Boston area.

In 2022, Pete was promoted to Vice President of the Special Projects Division, where he continued to lead one of Turner’s most dynamic teams. His focus on developing people, fostering collaboration, and maintaining a culture of safety and integrity contributed to sustained success across multiple market sectors.

Today, Pete serves as Vice President and General Manager of Turner Construction’s Boston Business Unit, leading a team of more than 450 employees. In this role, he is responsible for the overall strategic vision, business operations, and client engagement across all of Turner’s Boston-area projects. Pete oversees preconstruction, operations, and business development efforts, ensuring alignment with Turner’s core values and national objectives. He is dedicated to driving innovation, supporting employee growth, and delivering exceptional outcomes for clients throughout the region.

John L. Joyal, Ph.D.

Chief Operating Officer, Research, Moderna

John L. Joyal, Ph.D. joined Moderna, Inc. in 2013 and currently serves as the Chief Operating Officer, Research, and Cambridge Campus Site Head, ensuring efficiency in business and laboratory operations across the Research and Early Development landscape at Moderna’s Cambridge, MA campus. He previously led Moderna’s Biological Science department responsible for the analytical, molecular, biochemical and cellular evaluation of novel mRNA and delivery systems to advance Moderna’s platform technology. Prior to joining Moderna, Dr. Joyal was Vice President of Discovery Research at Molecular Insight Pharmaceuticals from 2005-2013, where he led the advancement of radiopharmaceuticals for cancer and cardiovascular disease. He was Director of Discovery Research at Phylogix, Inc. from 2004-2005 focusing on growth factor signaling involved in chemotherapeutic recovery, and earlier in his career held several positions of increasing responsibility at Praecis Pharmaceuticals from 1997-2004, culminating in Director of Cell Biology, where he developed peptide-based therapeutics for oncology, inflammation, infectious disease and neurological disorders. Dr. Joyal received his Ph.D. from Tufts University in 1994 studying mitochondrial physiology and cellular bioenergetics. He did his post-doctoral training at Brigham and Women’s Hospital/Harvard Medical School from 1994-1997 examining the interaction of the calcium sensing protein, calmodulin, with IQGAP1 and other proteins involved in breast carcinogenesis and growth factor signaling.

Jeff Lowenberg

Senior Vice President of Development, BXP

Jeff Lowenberg is a Senior Vice President of Development at BXP. Jeff has over 25 years of commercial real estate development experience with BXP, GID and National Development. Jeff’s current responsibilities include managing all of BXP’s development activities in Cambridge, highlighted by the two million square foot BXP Life Sciences Center. Project components include a new 573,000 square foot research facility for AstraZeneca, Vega, a 39-story, 439-unit apartment tower, a first of its kind below grade electrical substation for Eversource and a future 570,000 life science building. Jeff holds a Bachelor of Science in Natural Resource Planning from Humboldt State University and an MBA from the University of North Carolina-Chapel Hill.

Fiona Mack, Ph.D.

Head of East North America, External Scientific Innovation, Johnson & Johnson

Fiona Mack is currently the Head of Johnson & Johnson, East North America, External Scientific Innovation located at the Innovation Centre in Boston. In this role she leads the Innovation Center team to build, advance, and manage the External R&D portfolio of co-investments spanning across pharmaceutical, consumer health and medical devices.

Previously, she was Vice President, Head of Bayer Co.Lab Cambridge, US, which is a part of the Business Development & Licensing function. In this role, she is building a life science incubator to accelerate innovations within the fields of cell and gene therapy, oncology, immunology, cardiovascular medicine, and digital health.

Prior to joining Bayer, as Head of JLABS@ TMC, Fiona was responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming, and P&L. She catalyzed and supported the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer, and healthtech sectors.

Fiona has held senior leadership positions at Ipsen, Roche and Pfizer supporting external innovation efforts to expand Rare Disease, Neuroscience and Oncology portfolios.

Fiona earned her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and her undergraduate degree in Biology from Cornell University. Her innovative work has been published in high impact journals and she also has several granted patents.

Rose McCarthy

Senior Director of Site Operations, AstraZeneca

In her current role as Senior Director of Site Operations at AstraZeneca’s Waltham R&D facility, Rose McCarthy is responsible for the oversight of the Site Operations team including Laboratory Operations, Facilities Operations, Site Services, Logistics, Engineering, Security and Safety Health & Environmental programs. Rose is also responsible for the Operational Readiness team, actively preparing and planning for the smooth transition to AstraZeneca’s new strategic R&D site in Kendall Square, due for completion in 2026.

Prior to joining AZ, she held key various leadership positions at organizations such as Bristol Myers Squibb, Novartis, WuXi Biologics, NIBRT, and SK biotek Ireland Limited, where she gained wide-ranging experience across operations, supply chain, quality, science and technology. She has a proven record of delivering results through people while adapting to business and strategic challenges in the biopharmaceutical arena. She has extensive international leadership experience and has demonstrated the ability to build successful business partnerships.

Rose earned a bachelor’s degree in Chemical Engineering from University College Dublin, however her passion for lifelong learning has seen her complement her primary qualification by specialized training in lean systems and health and safety from the University of Limerick. In addition, she pursued a Diploma in Lean Systems and a Higher National Diploma in Health and Safety. Beyond professional
accomplishments, Rose is driven by a desire to contribute to collaborative endeavors aimed at enhancing patient outcomes, particularly in the realm of cancer and other life-threatening illnesses. Ultimately, she aspires to leave behind a legacy of meaningful impact, enabling individuals and families to cherish more moments together.

Bert Ng

Director of Public Policy, Alnylam Pharmaceuticals

Bert Ng is Director of Public Policy at Alnylam Pharmaceuticals, where he leads the company’s federal public policy strategy and supports cross‑functional initiatives that relate to reimbursement, patient access, and health policy. He also helps shape Alnylam’s engagement in Massachusetts and works with state and local leaders on the company’s continued growth in the Commonwealth.

He brings extensive experience in reimbursement and patient access through a career spanning across biopharma, consulting, and state government. His work at Deloitte and Genentech focused on federal public policy strategy, Inflation Reduction Act implementation, and healthcare payment and delivery reform. Earlier in his career, he served as committee staff in the Massachusetts House of Representatives, where he contributed to the development of Chapter 224; conducted healthcare cost analyses at the Massachusetts Health Policy Commission; and oversaw the Mass HIway statewide health information exchange at the Massachusetts Executive Office of Health and Human Services.

Bert is actively engaged in the region’s life sciences and innovation ecosystem, collaborating with public and private organizations across the state. He is committed to strengthening partnerships between industry, government, and community stakeholders to support Kendall Square’s leadership in scientific and economic innovation.

He is a graduate of BC High and Babson College and earned his law degree from Suffolk University Law School. He lives with his family in Brookline.

Dennis O’Donnell

Managing Director, Investments, DivcoWest

Dennis O’Donnell is a Managing Director on the Investments team at DivcoWest. In this role, Dennis is responsible for managing asset performance, overseeing the operations, and leasing DivcoWest assets in the Boston Market. His leadership is essential in maintaining the Boston Portfolio’s strong tenant, investor, and lender relations. Dennis collaborates with multiple teams, including Commercial Leasing, Marketing, Finance and Accounting, Development, Portfolio Management, IR, and Property Management.

Prior to joining DivcoWest in 2019, Dennis was an Asset Manager with Albany Road Real Estate Partners in Boston and held numerous roles at Colony Capital from 2005-2015.

Dennis holds his undergraduate degree in Anthropology at Harvard College and a Masters of Business Administration from F.W. Olin Graduate School of Business at Babson College. Dennis also holds a seat on the Board for the East Cambridge Business Association.

Geeta Pradhan

President, Cambridge Community Foundation

Geeta brings a deep background in government and philanthropy to the Cambridge Community Foundation, as well as expertise in community development, urban design and nonprofit research to her role as the Foundation’s first president.

She served as a foundation leader overseeing strategic initiatives at the Boston Foundation. As part of that work, she led the development of the Fairmount Corridor, organized the Massachusetts Nonprofit Network, co-founded the Boston Indicators Project and directed the New Economy Initiative using technology and data to drive social change.

Geeta serves on the Family Policy Council for Cambridge, is a member of the Birth to Third Grade Partnership Steering Committee, district planning committees for the Cambridge Superintendent of Schools, and the Mayor’s Women’s Pay Equity Committee.She studied architecture in India and received her masters from the Harvard Graduate School of Design.

Eric Quadrino

Owner, Sulmona Restaurant

Eric Quadrino has owned and operated various restaurants across Kendall Square since 2008. He is currently an owner and financial controller in Sulmona Restaurant Group, Mex Taqueria & Bar, and Mexcito Restaurant. Eric began his career in financial services with Citigroup Asset Management before pursuing his true passions of food and hospitality. He enjoys spending time with his family, food, wine, and Michigan Athletics. Go Blue!

Patrick Rowe

Senior Vice President, Head of Cambridge Real Estate, MITIMCo

Patrick joined MITIMCo in 2007. He leads the portfolio and asset management teams within the real estate group. His responsibilities include developing and implementing the investment strategy, long-term business planning, and near-term execution. He serves as a member of the real estate management committee that is responsible for establishing investment strategy and making all investment recommendations.

Prior to joining MITIMCo, he was with KSS Realty Partners in the development group. Patrick graduated from MIT with a Master of Science in Real Estate Development and earned a Bachelor of Arts from Dartmouth College.

Rhett Smith

Interim CEO, The Engine

Rhett Smith is Interim CEO of The Engine, the nonprofit built by MIT to support Tough Tech founders as they move breakthrough science from the lab to commercial impact. He joined The Engine in 2021 and served as Chief Operating Officer, leading labs, shops, facilities, operations, programs, and finance for a community of more than 160 resident companies. Before The Engine, Rhett held leadership roles in education, nonprofits, and finance, including Director of Operations at Roxbury Prep. He holds an MBA from Georgetown University.

Sandra Yi-Fuller

Head of Corporate Responsibility & Reporting, Biogen

Sandra drives Biogen’s corporate responsibility and reporting work, helping steer the company’s environmental, social and governance focus areas and priorities. She loves finding the stories that showcase how employees live the company’s purpose, and partnering with leaders on how Biogen is advancing a healthier and more equitable world.

Her career has spanned industries and cities. In Anchorage, Alaska she worked for KTUU-TV, the NBC affiliate; and a boutique PR/marketing agency. In The Netherlands and Houston, Texas, she worked for Shell in a variety of roles. Highlights of her career includes delivering Biogen’s first DE&I report, responding to incidents with Greenpeace protestors and helping U.S. Sen. Lisa Murkowski win a write-in campaign. Sandra graduated from Pacific University in Oregon, majoring in literature and art. Since then, she has also learned how to escape from a sinking helicopter.

About